✦ LIBER ✦

Randomized trial of carboplatin (CBDCA) and etoposide (E) administered either IV in a three-day schedule or in a protracted oral mode in non-small cell lung cancer (NSCLC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prolonged administration of oral etoposi

✍ Jeremic, Branislav; Shibamoto, Yuta; Acimovic, Ljubisa; Milicic, Biljana; Milisa 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Prolonged oral versus high-dose intraven

✍ Jeremic, Branislav; Shibamoto, Yuta; Milicic, Biljana; Milisavljevic, Slobodan; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Phase I–II trial of carboplatin (CBDCA)

✍ Massutí, B.; Barneto, I.; Meana, J.A.; Herrero, J.; Picó, C.; Aranda, E.; García 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 319 KB

O-217 A randomized phase III trial of ge

✍ Treat, Joe; Chandra, Belani P.; Edelman, Martin; Socinski, Mark; Gonin, R.; Ansa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB

243 Spanish lung cancer group randomized

✍ Felip, E.; Moreno, I.; Canela, M.; Alberola, V.; Gómez-Codina, J.; González-Larr 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 143 KB

A three-arms phase III randomised trial

✍ J.P. Sculier; J.J. Lafitte; M. Paesmans; J. Lecomte; T. Berghmans; M.C. Florin; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 185 KB